NCT03705793View on ClinicalTrials.gov

Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

February 15, 2020

Study Completion Date

March 15, 2020

Conditions
Chronic Rhinosinusitis (Diagnosis)Allergic RhinosinusitisChronic Eosinophilic Rhinosinusitis
Interventions
DRUG

Mometasone Furoate Nasal Irrigation

Participants will undergo an 8-week treatment course that includes nasal saline irrigation with mometasone powder and placebo nasal spray.

DRUG

Mometasone Nasal Spray

Participants will undergo an 8-week treatment course that includes placebo saline irrigation with mometasone nasal spray.

Trial Locations (2)

63110

Washington University School of Medicine, St Louis

Washington University, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03705793 - Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis | Biotech Hunter | Biotech Hunter